Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project

Background and objective: Papillary renal cell carcinoma (pRCC) is a rare disease. The optimal treatment of metastatic pRCC is still unclear. We evaluated real-world treatment outcomes of first-line treatment in this cohort in Germany. Methods: Patients with advanced or metastatic pRCC were eligible...

Full description

Bibliographic Details
Published in:	European Urology Open Science
Main Authors:	Thomas Hilser, Jozefina Casuscelli, Can Aydogdu, Stefanie Zschäbitz, Marco Julius Schnabel, Emily Rinderknecht, Angelika Mattigk, Martin Schostak, Anna-Lisa Volk, Philipp Ivanyi, Jonas Wiegmann, Christopher Darr, Luka Flegar, Subhajit Mandal, Katrin Schlack, Daniel Seidl, Analena Handke, Melanie Klee, Tim Nestler, Marc Rehlinghaus, Sameh Hijazi, Axel Heidenreich, Viktor Grünwald, Pia Paffenholz
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Subjects:	Papillary renal cell cancer Immune checkpoint inhibitor Tyrosine kinase inhibitor First-line treatment
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168325002447

Similar Items

Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
by: Stefanie Zschäbitz, et al.
Published: (2023-07-01)

New hopes and promises in the treatment of ovarian cancer focusing on targeted treatment—a narrative review
by: Małgorzata Satora, et al.
Published: (2024-06-01)

Immune-related hepatic adverse events in renal cell carcinoma patients treated with immune checkpoint inhibitors: a retrospective study
by: Amer Saleh, et al.
Published: (2025-09-01)

Precision Medicine for Pediatric Glioma and NF1-Associated Tumors: The Role of Small Molecule Inhibitors
by: Samuele Renzi, et al.
Published: (2025-05-01)

The effect of chemotherapy regimens in male germ cell tumors on the development of primary hypogonadism
by: Analena Handke, et al.
Published: (2024-11-01)

Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications
by: Agata Gitlin-Domagalska, et al.
Published: (2020-11-01)

α-Glucosidase, Angiotensin-converting Enzyme, and Acetylcholinesterase Inhibitory Activities of a Marine Red Alga Galaxaura oblongata
by: Kimnard Joseph Magsacay Duat, et al.
Published: (2023-09-01)

Small Molecules in the Management of Psoriasis and Psoriatic Arthritis
by: Venkata Chalam Konakanchi, et al.
Published: (2024-06-01)

Evolution der Herbizidresistenz in Alopecurus myosuroides und Apera spica-venti im deutschen Getreideanbau der letzten 15 Jahre
by: Petersen, Jan, et al.
Published: (2020-03-01)

5-Nitro-3-(2-(4-phenylthiazol-2-yl)hydrazineylidene)indolin-2-one derivatives inhibit HIV-1 replication by a multitarget mechanism of action
by: Angela Corona, et al.
Published: (2023-06-01)

Current advances in immunotherapy for cancer
by: Indrajit Desai, et al.
Published: (2024-12-01)

Unleashing the Power of Synthetic Lethality: Augmenting Treatment Efficacy through Synergistic Integration with Chemotherapy Drugs
by: Yajing Du, et al.
Published: (2023-10-01)

Permethrin as a Potential Furin Inhibitor through a Novel Non-Competitive Allosteric Inhibition
by: Dongyan Feng, et al.
Published: (2023-02-01)

Aromatic Metal Corrosion Inhibitors
by: Jessica Roscher, et al.
Published: (2024-10-01)

Entinostat-Bortezomib Hybrids against Multiple Myeloma
by: Angelica Ferro, et al.
Published: (2023-02-01)

Isatin-Hydrazones with Multiple Receptor Tyrosine Kinases (RTKs) Inhibitory Activity and In-Silico Binding Mechanism
by: Huda S. Al-Salem, et al.
Published: (2021-04-01)

Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery
by: Jielin Li, et al.
Published: (2021-05-01)

Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review
by: Yu CW, et al.
Published: (2020-11-01)

The role and action mechanism of inhibitors in solutions for etching steel
by: Bosiljka Ljubičić, et al.
Published: (2015-12-01)

Novel Multitarget Therapies for Lung Cancer and Respiratory Disease
by: Masako Yumura, et al.
Published: (2020-09-01)

Epigenetic modulation of immunotherapy cofactors to enhance tumor response in lung cancer
by: Anuhya Kommalapati, et al.
Published: (2021-01-01)

REPEATED USE OF BRAF AND MEK INHIBITORS IN METASTATIC MELANOMA PATIENTS AFTER PROFRESSION ON BRAF AND МЕК INHIBITORS. LITERATURE REVIEW AND CLINICAL OBSERVATION
by: I. V. Samoylenko, et al.
Published: (2017-11-01)

Screening of selective histone deacetylase inhibitors by proteochemometric modeling
by: Wu Dingfeng, et al.
Published: (2012-08-01)

Editorial: Combination strategies in the treatment of Melanoma
by: Paolo Antonio eAscierto
Published: (2016-03-01)

Calcineurin inhibitors in steroid and anti‐TNF‐alpha refractory immune checkpoint inhibitor colitis
by: Eva Zhang, et al.
Published: (2021-05-01)

New Drugs for Treating Dyslipidemia: Beyond Statins
by: Chang Ho Ahn, et al.
Published: (2015-04-01)

Clinical and Molecular Predictors of Response and Survival in Patients with Urothelial Carcinoma Treated with Enfortumab Vedotin: A Systematic Review and Meta-analysis
by: Mohammed Altenni, et al.
Published: (2025-12-01)

NEW ANTIPLATELET DRUGS. PART 2
by: A. B. Sumarokov
Published: (2016-01-01)

Risk of new-onset and recurrent uveitis with different biologics for ankylosing spondylitis: a network meta-analysis
by: Xu Zhao, et al.
Published: (2025-06-01)

Targeting WEE1 and asciminib suppresses ABL-tyrosine kinase inhibitor-resistant chronic myeloid leukemia cells
by: Seiichi Okabe, et al.
Published: (2025-07-01)

JAK Inhibitor Upadacitinib Induces Remission in Refractory Immune‐Related Colitis Triggered by CTLA‐4 and PD‐1 Inhibitor Combination Therapy in Malignant Pleural Mesothelioma: A Case Report
by: Masashi Kono, et al.
Published: (2024-10-01)

Association between Immunosuppressive Therapy Utilized in the Treatment of Autoimmune Disease or Transplant and Cancer Progression
by: Amanda Reyes, et al.
Published: (2022-12-01)

Therapeutic Targets in Allergic Conjunctivitis
by: Bisant A. Labib, et al.
Published: (2022-04-01)

Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis
by: Alessandro Inno, et al.
Published: (2024-02-01)

Treatment of Advanced Melanoma: Past, Present and Future
by: Taku Fujimura, et al.
Published: (2020-09-01)

Living with Psoriasis Vulgaris and Multi-Treatment Failure: A Patient and Dermatologist Perspective
by: Riley K. Spencer, et al.
Published: (2023-03-01)

Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond
by: Khushboo Chauhan, et al.
Published: (2024-08-01)

The pharmacoepigenetic paradigm in cancer treatment
by: Belén Ocaña-Paredes, et al.
Published: (2024-04-01)

In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus
by: Phaedra Eleftheriou, et al.
Published: (2020-05-01)

New hepatitis C therapies in clinical development
by: Vermehren Johannes, et al.
Published: (2011-07-01)